Evidence map›Paper›PMID 34752943›Full record

ArticleJournal of anxiety disorders2021

When a nightmare comes true: Change in obsessive-compulsive disorder over the first months of the COVID-19 pandemic.

Lena Jelinek, Ulrich Voderholzer, Steffen Moritz, Hannes Per Carsten, Anja Riesel, Franziska Miegel

Open access · greenAbstract read
In one paragraph

Article in Journal of anxiety disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lena JelinekDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Germany. Electronic address: ljelinek@uke.de.
Ulrich VoderholzerDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Germany; Schoen Clinic Roseneck, Prien am Chiemsee, Germany; Department of Psychiatry and Psychotherapy, University Hospital of Freiburg, Germany.
Steffen MoritzDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Germany.
Hannes Per CarstenDepartment of Clinical Psychology and Psychotherapy, University of Hamburg, Germany.
Anja RieselDepartment of Clinical Psychology and Psychotherapy, University of Hamburg, Germany.
Franziska MiegelDepartment of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Germany.
Universität Hamburg · DELMU Klinikum · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of the COVID-19 pandemic has particularly affected people with obsessive-compulsive disorder (OCD). Exacerbation of obsessive-compulsive symptoms (OCS) has been suspected for those with contamination-related OCD (C-OCD). However, the course of OCS over the ongoing pandemic remains unclear. We assessed 268 participants with OCD (n = 184 with C-OCD) in an online survey at the beginning of the pandemic in Germany, reassessing 179 participants (66.8%, 104 C-OCD) three months later. We assessed severity of OCD (OCI-R), depression (PHQ-9), experiential avoidance, as well as functional and dysfunctional beliefs. Overall, OCS and depressive symptoms did not substantially change over time. However, when people with and without C-OCD were compared, symptoms improved in patients without C-OCD (nC-OCD) but remained stable in patients with C-OCD over time. Symptom improvement was associated with male gender, higher initial OCI-R, and nC-OCD. Experiential avoidance and beliefs at the beginning of the pandemic did not generally predict change in OCS. People with OCD, particularly those with nC-OCD, showed tentative signs for signs of adapting, whereas distress in those with C-OCD remained at a high level, underlining the burden for these patients. Clinicians should be informed about how to maintain effective treatment for C-OCD during a pandemic.

Indexed as

COVID-19Obsessive-Compulsive DisorderDreamsHumansMalePandemicsSARS-CoV-2Contamination fearCOVID-19Experiential avoidanceObsessive-compulsive disorderPandemicSARS-CoV-2

Identifiers

PMID34752943
PMCPMC8590107
OpenAlexW3209534565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.